Nanotechnological Strategies for Protein Delivery
- PMID: 29693640
- PMCID: PMC6100203
- DOI: 10.3390/molecules23051008
Nanotechnological Strategies for Protein Delivery
Abstract
The use of therapeutic proteins plays a fundamental role in the treatment of numerous diseases. The low physico-chemical stability of proteins in physiological conditions put their function at risk in the human body until they reach their target. Moreover, several proteins are unable to cross the cell membrane. All these facts strongly hinder their therapeutic effect. Nanomedicine has emerged as a powerful tool which can provide solutions to solve these limitations and improve the efficacy of treatments based on protein administration. This review discusses the advantages and limitations of different types of strategies employed for protein delivery, such as PEGylation, transport within liposomes or inorganic nanoparticles or their in situ encapsulation.
Keywords: PEGylation; liposomes; nanoparticles; polymeric nanocapsules; protein delivery system; protein therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Liposomes and nanotechnology in drug development: focus on ocular targets.Int J Nanomedicine. 2013;8:495-503. doi: 10.2147/IJN.S30725. Epub 2013 Feb 14. Int J Nanomedicine. 2013. PMID: 23439842 Free PMC article. Review.
-
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.J Pharm Sci. 2014 Jan;103(1):29-52. doi: 10.1002/jps.23773. Epub 2013 Nov 25. J Pharm Sci. 2014. PMID: 24338748 Free PMC article. Review.
-
Nanomedicine in Bladder Cancer Therapy.Int J Mol Sci. 2024 Sep 26;25(19):10388. doi: 10.3390/ijms251910388. Int J Mol Sci. 2024. PMID: 39408718 Free PMC article. Review.
-
Liposomal drug delivery systems: from concept to clinical applications.Adv Drug Deliv Rev. 2013 Jan;65(1):36-48. doi: 10.1016/j.addr.2012.09.037. Epub 2012 Oct 1. Adv Drug Deliv Rev. 2013. PMID: 23036225 Review.
-
Lipid nanocapsules: a new platform for nanomedicine.Int J Pharm. 2009 Sep 11;379(2):201-9. doi: 10.1016/j.ijpharm.2009.04.026. Epub 2009 May 4. Int J Pharm. 2009. PMID: 19409468 Review.
Cited by
-
Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment.Int J Nanomedicine. 2021 Feb 17;16:1261-1280. doi: 10.2147/IJN.S283416. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33628020 Free PMC article. Review.
-
Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application.J Mater Sci Mater Med. 2019 Aug 7;30(8):93. doi: 10.1007/s10856-019-6294-y. J Mater Sci Mater Med. 2019. PMID: 31392433
-
Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine.Int J Nanomedicine. 2021 Jun 21;16:4197-4208. doi: 10.2147/IJN.S315444. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34188469 Free PMC article.
-
Polymeric Nanostructures Containing Proteins and Peptides for Pharmaceutical Applications.Polymers (Basel). 2022 Feb 16;14(4):777. doi: 10.3390/polym14040777. Polymers (Basel). 2022. PMID: 35215689 Free PMC article. Review.
-
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?Int J Biol Macromol. 2021 Dec 1;192:1040-1057. doi: 10.1016/j.ijbiomac.2021.10.015. Epub 2021 Oct 14. Int J Biol Macromol. 2021. PMID: 34656540 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources